These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33299496)

  • 1. Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis.
    Yu LX; Liu QF; Feng JH; Li SS; Gu XX; Xiong Y; Qiang-Sun ; Ye JM
    Dis Markers; 2020; 2020():4923970. PubMed ID: 33299496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis.
    Zhang AH; Guo WK; Yu L; Liu WH
    Kidney Blood Press Res; 2019; 44(3):396-404. PubMed ID: 31079116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.
    Manou E; Thodis E; Arsos G; Pasadakis P; Panagoutsos S; Papadopoulou D; Papagianni A
    Kidney Blood Press Res; 2020; 45(6):900-915. PubMed ID: 33040068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.
    Milovanova LY; Dobrosmyslov IA; Milovanov YS; Taranova MV; Kozlov VV; Milovanova SY; Kozevnikova EI
    Ter Arkh; 2018 Jun; 90(6):48-54. PubMed ID: 30701904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis.
    Yu L; Kang L; Ren XZ; Diao ZL; Liu WH
    Kidney Blood Press Res; 2018; 43(4):1174-1182. PubMed ID: 30064142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.
    Li Z; Liu S; Liang X; Wang W; Fei H; Hu P; Chen Y; Xu L; Li R; Shi W
    Int Urol Nephrol; 2014 Jan; 46(1):141-9. PubMed ID: 23793619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.
    Seiler S; Rogacev KS; Roth HJ; Shafein P; Emrich I; Neuhaus S; Floege J; Fliser D; Heine GH
    Clin J Am Soc Nephrol; 2014 Jun; 9(6):1049-58. PubMed ID: 24677555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis.
    Liu QF; Li SS; Yu LX; Feng JH; Xue LL; Lu GY
    Ther Adv Chronic Dis; 2020; 11():2040622320940176. PubMed ID: 35154625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis.
    Zheng S; Zheng Y; Jin L; Zhou Z; Li Z
    Iran J Public Health; 2018 Apr; 47(4):510-518. PubMed ID: 29900135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.
    Buiten MS; de Bie MK; Bouma-de Krijger A; van Dam B; Dekker FW; Jukema JW; Rabelink TJ; Rotmans JI
    BMC Nephrol; 2014 Dec; 15():197. PubMed ID: 25495997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-Sensitive Cardiac Troponin T for Prediction of Cardiovascular Outcomes in Stable Maintenance Hemodialysis Patients: A 3-Year Prospective Study.
    Sun L; Wang Y; Zhang N; Xie X; Ding M; Guo H; Li F; Wang X
    Kidney Blood Press Res; 2021; 46(4):484-494. PubMed ID: 34167109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton pump inhibitor usage is associated with higher all-cause mortality and CV events in peritoneal dialysis patients.
    Zeng Y; Liu L; Zhu L; Zhan X; Peng F; Feng X; Zhou Q; Zhang Y; Wang Z; Liang J; Li J; Wen Y
    Ren Fail; 2022 Dec; 44(1):407-414. PubMed ID: 35236240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association of Klotho gene polymorphism with the mortality of patients on maintenance dialysis.
    Ko GJ; Lee YM; Lee EA; Lee JE; Bae SY; Park SW; Park MS; Pyo HJ; Kwon YJ;
    Clin Nephrol; 2013 Oct; 80(4):263-9. PubMed ID: 23993164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Klotho is associated with mortality and cardiovascular events in hemodialysis.
    Memmos E; Sarafidis P; Pateinakis P; Tsiantoulas A; Faitatzidou D; Giamalis P; Vasilikos V; Papagianni A
    BMC Nephrol; 2019 Jun; 20(1):217. PubMed ID: 31185930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prognostic Role of Klotho in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis.
    Liu QF; Yu LX; Feng JH; Sun Q; Li SS; Ye JM
    Dis Markers; 2019; 2019():6468729. PubMed ID: 31275449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of arterial stiffness on adverse cardiovascular outcomes and mortality in peritoneal dialysis patients.
    Sipahioglu MH; Kucuk H; Unal A; Kaya MG; Oguz F; Tokgoz B; Oymak O; Utas C
    Perit Dial Int; 2012; 32(1):73-80. PubMed ID: 21454392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between pinch strength, cardiovascular events and all-cause mortality in patients undergoing maintenance hemodialysis.
    Yang Y; Liu L; Li Y; Tan R; Zhong X; Liu Y; Liu Y
    BMC Nephrol; 2024 May; 25(1):150. PubMed ID: 38698329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Galectin-3 levels and all-cause and cardiovascular mortality in maintenance hemodialysis patients: a prospective cohort study.
    Liu S; Wu Q; Zhang S; Wang Z; Liu H; Teng L; Xiao P; Lu Y; Wang X; Dong C; Xiao J; Zhang J
    BMC Nephrol; 2022 Jan; 23(1):5. PubMed ID: 34979958
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline Serum Magnesium Level and Its Variability in Maintenance Hemodialysis Patients: Associations with Mortality.
    Wu L; Cai K; Luo Q; Wang L; Hong Y
    Kidney Blood Press Res; 2019; 44(2):222-232. PubMed ID: 30921805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutrophil to Lymphocyte Ratio Predicts Adverse Cardiovascular Outcome in Peritoneal Dialysis Patients Younger than 60 Years Old.
    Zeng Y; Chen Z; Chen Q; Zhan X; Long H; Peng F; Zhang F; Feng X; Zhou Q; Liu L; Peng X; Evergreen Tree Nephrology Association ; Guo G; Zhang Y; Wang Z; Wen Y; Li J; Liang J
    Mediators Inflamm; 2020; 2020():4634736. PubMed ID: 32565726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.